Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2025-12-29 @ 5:19 PM
Study NCT ID:
NCT00972595
Status:
COMPLETED
Last Update Posted:
2015-08-19
First Post:
2009-09-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-06
Start Date Type:
None
Primary Completion Date:
2004-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-09
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-03
First Submit QC Date:
None
Study First Post Date:
2009-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-05-19
Results First Submit QC Date:
None
Results First Post Date:
2010-06-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-18
Last Update Post Date:
2015-08-19
Last Update Post Date Type:
ESTIMATED